However, there were no significant differences between the nonprogress and progress groups in terms of GCS score on admission, hypertension, diabetes, neutrophil count, platelet levels, dNLR, prothrombin time, APTT, and creatinine levels (P > 0.05). This evidence concerns the gene F2 and diabetes mellitus.